The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-β-arrestin complexes after receptor endocytosis
Open accessAbstract
beta-Arrestins bind agonist-activated G protein-coupled receptors (GPCRs) and mediate their desensitization and internalization. Although beta-arrestins dissociate from some receptors at the plasma membrane, such as the beta2 adrenergic receptor, they remain associated with other GPCRs and internalize with them into endocytic vesicles. Formation of stable receptor-beta-arrestin complexes that persist inside the cell impedes receptor resensitization, and the aberrant formation of these complexes may play a role in GPCR-based diseases (Barak, L. S., Oakley, R. H., Laporte, S. A., and Caron, M. G. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 93-98). Here, we investigate the molecular determinants responsible for sustained receptor/beta-arrestin interactions. We show in real time and in live human embryonic kidney (HEK-293) cells that a beta-arrestin-2-green fluorescent protein conjugate internalizes into endocytic vesicles with agonist-activated neurotensin-1 receptor, oxytocin receptor, angiotensin II type 1A receptor, and substance P receptor. Using receptor mutagenesis, we demonstrate that the ability of beta-arrestin to remain associated with these receptors is mediated by specific clusters of serine and threonine residues located in the receptor carboxyl-terminal tail. These clusters are remarkably conserved in their position within the carboxyl-terminal domain and serve as primary sites of agonist-dependent receptor phosphorylation. In addition, we identify a beta-arrestin mutant with enhanced affinity for the agonist-activated beta2-adrenergic receptor that traffics into endocytic vesicles with receptors that lack serine/threonine clusters and normally dissociate from wild-type beta-arrestin at the plasma membrane. By identifying receptor and beta-arrestin residues critical for the formation of stable receptor-beta-arrestin complexes, these studies provide novel targets for regulating GPCR responsiveness and treating diseases resulting from abnormal GPCR/beta-arrestin interactions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, (Vargas-Pinilla et al., 2015) identified a new phosphorylation site in the OTR of Callithrix at R149S, and the shortening of a Ser cluster in the OTR of Saguinus that is important for β-arrestin mediated desensitization and receptor recycling (Innamorati et al., 1998; Oakley et al., 2001; Vargas-Pinilla et al., 2015).”
From Neuropeptide diversity and the regulation of social behavior in New World primates (2016) · cites this paper as Oakley et al., 2001
Citations
Cites
β-Arrestin-Dependent Formation of β 2 Adrenergic Receptor-Src Protein Kinase Complexes
Luttrell, L. M., Ferguson, S. S. G., Daaka, Y., Miller, W. E., Maudsley, S. R., Rocca, G. J. D., Lin, F., Kawakatsu, H., Owada, K. M., Luttrell, D. K., et al. (1999) · Science · doi:10.1126/science.283.5402.655 · Cited by 1,473
β-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor
Goodman, O. B., Krupnick, J. G., Santini, F., Gurevich, V. V., Penn, R. B., Gagnon, A. W., Keen, J. H., & Benovic, J. (1996) · Nature · doi:10.1038/383447a0 · Cited by 1,383
β-Arrestin: a Protein that Regulates β-adrenergic Receptor Function
Lohse, M. J., Benovic, J., Codina, J., Caron, M. G., & Lefkowitz, R. J. (1990) · Science · doi:10.1126/science.2163110 · Cited by 1,222
THE ROLE OF RECEPTOR KINASES AND ARRESTINS IN G PROTEIN–COUPLED RECEPTOR REGULATION
Krupnick, J. G., & Benovic, J. (1998) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.289 · Cited by 1,121
Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2
Bohn, L., Lefkowitz, R. J., Gainetdinov, R. R., Peppel, K., Caron, M. G., & Lin, F. (1999) · Science · doi:10.1126/science.286.5449.2495 · Cited by 1,079
Role of β-Arrestin in Mediating Agonist-Promoted G Protein-Coupled Receptor Internalization
Ferguson, S. S. G., Downey, W. E., Colapietro, A.-M., Barak, L. S., Ménard, L., & Caron, M. G. (1996) · Science · doi:10.1126/science.271.5247.363 · Cited by 974
Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas
Parma, J., Duprez, L., SANDE, J. V., Cochaux, P., Gervy, C., Mockel, J., Dumont, J. E., & Vassart, G. (1993) · Nature · doi:10.1038/365649a0 · Cited by 914
Oakley, R. H., Laporte, S. A., Holt, J. A., Caron, M. G., & Barak, L. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910348199 · Cited by 882
DeFea, K., Zalevsky, J., Thoma, M. S., Déry, O., Mullins, R. D., & Bunnett, N. W. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.6.1267 · Cited by 820
β-Arrestin 2: A Receptor-Regulated MAPK Scaffold for the Activation of JNK3
McDonald, P. H., Chow, C.-W., Miller, W. E., Laporte, S. A., Field, M. E., Lin, F., Davis, R. J., & Lefkowitz, R. J. (2000) · Science · doi:10.1126/science.290.5496.1574 · Cited by 818
Flagged first, then by citations
Research works printed but not linked: 1
- Roush, 1999, Mol. Pharmacol., 55, 855
Cited by
Sorted by citations
Items 101–200 of 456
Adie, E. J., Kalinka, S., Smith, L., Francis, M. J., Marenghi, A., Cooper, M. E., Briggs, M. S. J., Michael, N. P., Milligan, G., & Game, S. M. (2002) · BioTechniques · doi:10.2144/02335dd10 · Cited by 86
Sphingosine 1-Phosphate Receptor 1 Signaling in Mammalian Cells
Pyne, N. J., & Pyne, S. (2017) · Molecules · doi:10.3390/molecules22030344 · Cited by 85
“, V2 vasopressin receptor, V2R) and show sustained internalisation and signaling [13].”
InfluentialDevelopment of a BRET2 Screening Assay Using β-Arrestin 2 Mutants
Vrecl, M., Jørgensen, R., Pogačnik, A., & Heding, A. (2004) · SLAS DISCOVERY · doi:10.1177/1087057104263212 · Cited by 85
“The absence of any significant effect of the β-arr2 mutants on the BRET(2) signal observed for the NK1-R is probably due to the ability of this receptor to form stable complexes with wt βarrs.(6) Because phosphorylation-independent β-arr2 mutants bind to the activated form of the receptor, it seems that NK1-R phosphor…”
BackgroundIntracellular trafficking of hormone receptors
Gáborik, Z., & Hunyady, L. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.06.009 · Cited by 85
β-Arrestins and G Protein-Coupled Receptor Trafficking
Kang, D. S., Tian, X., & Benovic, J. (2013) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-391862-8.00005-3 · Cited by 85
Genetic, epigenetic, and environmental factors controlling oxytocin receptor gene expression
Danoff, J. S., Wroblewski, K. L., Graves, A. J., Quinn, G. C., Perkeybile, A. M., Kenkel, W. M., Lillard, T. S., Parikh, H. I., Golino, H. F., Gregory, S. G., et al. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01017-5 · Cited by 85
“This novel OXTR fragment could also disrupt desensitization of OXTR after oxytocin stimulation, which is dependent on β-arrestin binding to serine triplets in the C-terminus of OXTR [54], by sequestering available β-arrestin.”
BackgroundMilasta, S., Evans, N. A., Ormiston, L., Wilson, S., Lefkowitz, R. J., & Milligan, G. (2005) · Biochemical Journal · doi:10.1042/bj20041745 · Cited by 84
Principles of odor coding in vertebrates and artificial chemosensory systems
Manzini, I., Schild, D., & Natale, C. D. (2021) · Physiological Reviews · doi:10.1152/physrev.00036.2020 · Cited by 90
Wei, H., Ahn, S., Barnes, W. G., & Lefkowitz, R. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406205200 · Cited by 83
Functional differences between two CRF-related diuretic hormone receptors in Drosophila
Hector, C. E., Bretz, C. A., Zhao, Y., & Johnson, E. C. (2009) · Journal of Experimental Biology · doi:10.1242/jeb.033175 · Cited by 83
“These different patterns of arrestin association are thought to reflect differences in signaling, as Family B receptors are thought to signal through the MAP-kinase pathway in the endosome, and impact resensitization kinetics (Oakley et al., 2001; Tohgo et al., 2003).”
BackgroundThe Angiotensin II AT1Receptor Structure-Activity Correlations in the Light of Rhodopsin Structure
Oliveira, L., Costa-Neto, C. M., Nakaie, C. R., Schreier, S., Shimuta, S. I., & Paiva, A. C. M. (2007) · Physiological Reviews · doi:10.1152/physrev.00040.2005 · Cited by 84
Illuminating the life of GPCRs
Böhme, I., & Beck‐Sickinger, A. G. (2009) · Cell Communication and Signaling · doi:10.1186/1478-811x-7-16 · Cited by 82
“Alternatively, primary antibodies can also be directly conjugated to fluorophores or enzymes [18,19].”
The role of somatostatin and dopamine D2 receptors in endocrine tumors
Gatto, F., & Hofland, L. J. (2011) · Endocrine Related Cancer · doi:10.1530/erc-10-0334 · Cited by 82
Berglund, M. M., Schober, D. A., Statnick, M. A., McDonald, P. H., & Gehlert, D. R. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051227 · Cited by 80
“…amino acid sequences of third intracellular loop and C terminus of the rhesus NPY receptors were searched for Ser-Thr clusters such as described by Oakley et al. (2001) and for clusters of basic amino acids such as described in DeGraff et al. (2002) with the consensus sequence B-X-X-B-B, where B…”
BackgroundMethodInfluentialβ-Arrestin- and G Protein Receptor Kinase-Mediated Calcium-Sensing Receptor Desensitization
Pi, M., Oakley, R. H., Gesty‐Palmer, D., Cruickshank, R. D., Spurney, R. F., Luttrell, L. M., & Quarles, L. D. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0450 · Cited by 80
Homo- and Hetero-oligomerization of Thyrotropin-releasing Hormone (TRH) Receptor Subtypes
Hanyaloglu, A. C., Seeber, R. M., Kohout, T. A., Lefkowitz, R. J., & Eidne, K. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209340200 · Cited by 78
Hasbi, A., Devost, D., Laporte, S. A., & Zingg, H. H. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0440 · Cited by 78
G Protein and β-Arrestin Signaling Bias at the Ghrelin Receptor
Evron, T., Peterson, S. M., Urs, N. M., Bai, Y., Rochelle, L. K., Caron, M. G., & Barak, L. S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.581397 · Cited by 75
“-Arrestin-2 Interaction with the GHSR1a in HEK293 Cells— A specific cluster of phosphorylated serine/threonine residues in the C terminus of class B GPCRs enables them to form stable complexes with -arrestin during endocytosis (37).”
Balakumar, P., & Jagadeesh, G. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0125 · Cited by 77
Osteoblast regulation via ligand-activated nuclear trafficking of the oxytocin receptor
Benedetto, A. D., Sun, L., Zambonin, C. G., Tamma, R., Nico, B., Calvano, C. D., Colaianni, G., Ji, Y., Mori, G., Grano, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419349111 · Cited by 77
“Mutations that prevent Ser phosphorylation, thus, inhibit Oxtr– Arrb interactions and receptor endocytosis (21).”
BackgroundCompeting G protein‐coupled receptor kinases balance G protein and β‐arrestin signaling
Heitzler, D., Durand, G., Gallay, N., Rizk, A., Ahn, S., Kim, J., Violin, J. D., Dupuy, L., Gauthier, C., Piketty, V., et al. (2012) · Molecular Systems Biology · doi:10.1038/msb.2012.22 · Cited by 83
“…this idea is consistent with previous results showing that the presence or absence of serine and threonine clusters in the receptor C terminus regulates the affinity of b-arrestin recruitment and the pattern of intracellular trafficking for a wide number of 7TMRs (Oakley et al, 2000, 2001).”
ResultSmith, M. P., Ayad, V. J., Mundell, S. J., McArdle, C. A., Kelly, E., & Bernal, A. L. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0031 · Cited by 76
Jørgensen, R., Martini, L., Schwartz, T. W., & Elling, C. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0312 · Cited by 76
“The NK-1 receptor is known to have a very high affinity for arrs (36).”
BackgroundThe Arrestin Fold: Variations on a Theme
Aubry, L., Guetta, D., & Klein, G. (2009) · Current Genomics · doi:10.2174/138920209787847014 · Cited by 74
“ters [27].”
Arrestin Interactions with G Protein-Coupled Receptors
Lohse, M. J., & Hoffmann, C. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-41199-1_2 · Cited by 73
“The key sequence determinants that distinguished class A and class B receptors in this and subsequent studies were distinct GRK phosphorylation sites, most notably in the C-termini of the receptors (Oakley et al. 2000, 2001; Tohgo et al. 2003).”
BackgroundNovel insights in somatostatin receptor physiology
Tulipano, G., & Schulz, S. (2007) · European Journal of Endocrinology · doi:10.1530/eje.1.02354 · Cited by 71
The signaling signature of the neurotensin type 1 receptor with endogenous ligands
Besserer‐Offroy, É., Brouillette, R. L., Lavenus, S. B., Froehlich, U., Brumwell, A., Murza, A., Longpré, J., Marsault, É., Grandbois, M., Sarret, P., et al. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.03.046 · Cited by 71
Smith, J. S., Alagesan, P., Desai, N. K., Pack, T. F., Wu, J., Inoue, A., Freedman, N. J., & Rajagopal, S. (2017) · Molecular Pharmacology · doi:10.1124/mol.117.108522 · Cited by 67
“The findings here support a model for a CXCR3 signaling barcode, in which posttranslational modifications in the receptor C-terminus regulate the affinity of barr recruitment and the pattern of GPCR intracellular trafficking (Oakley et al., 2000, 2001).”
BackgroundNeuropeptide diversity and the regulation of social behavior in New World primates
French, J. A., Taylor, J. H., Mustoe, A. C., & Cavanaugh, J. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.03.004 · Cited by 66
“…a new phosphorylation site in the OTR of Callithrix at 729R149S, and the shortening of a Ser cluster in the OTR of Saguinus 730that is important for b-arrestin mediated desensitization and 731receptor recycling (Innamorati et al., 1998; Oakley et al., 2001; 732Vargas-Pinilla et al., 2015).”
Oakley, R. H., Olivares-Reyes, J. A., Hudson, C. C., Flores-Vega, F., Dautzenberg, F. M., & Hauger, R. L. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00099.2006 · Cited by 67
Multitasking with neurotensin in the central nervous system
Dobner, P. R. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5128-x · Cited by 67
Yu, Y., Arttamangkul, S., Evans, C. J., Williams, J. T., & von Zastrow, M. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4315-08.2009 · Cited by 66
“Whereas many GPCRs (including MOR) rapidly dissociate from arrestins upon endocytosis, a subset of GPCRs (including the NK1R) are capable of driving pronounced sequestration of arrestins on endosomes (Oakley et al., 2001).”
BackgroundMin, L., Galet, C., & Ascoli, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106082200 · Cited by 66
Interactions between neurotensin receptors and G proteins
Pélaprat, D. (2006) · Peptides · doi:10.1016/j.peptides.2006.04.027 · Cited by 65
Selective Interaction of ARF1 with the Carboxy-Terminal Tail Domain of the 5-HT2A Receptor
Robertson, D. N., Johnson, M. S., Moggach, L. O., Holland, P. J., Lutz, E. M., & Mitchell, R. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.5.1239 · Cited by 65
“In a number of GPCRs, other intracellular loops and ct domains have also been implicated in interactions with heterotrimeric G proteins and arrestins (Wu et al., 1997; Oakley et al., 2001).”
BackgroundATP stimulates GRK-3 phosphorylation and β-arrestin-2-dependent internalization of P2X7 receptor
Feng, Y., Wang, L., Wang, Q., Li, X., Zeng, R., & Gorodeski, G. I. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00315.2004 · Cited by 64
Ubiquitin-dependent Down-regulation of the Neurokinin-1 Receptor
Cottrell, G. S., Padilla, B. E., Pikios, S., Roosterman, D., Steinhoff, M. S., Gehringer, D., Grady, E. F., & Bunnett, N. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603369200 · Cited by 64
Chen, X., Bai, B., Tian, Y., Du, H., & Chen, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.574020 · Cited by 61
“A specific serine/threonine cluster within the C terminus of most GPCRs has been identified as the key sites that undergo GRK phosphorylation and -arrestins association (37).”
BackgroundUsui, I., Imamura, T., Huang, J., Satoh, H., Shenoy, S. K., Lefkowitz, R. J., Hupfeld, C. J., & Olefsky, J. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.20.8929-8937.2004 · Cited by 61
Vargas-Pinilla, P., Paixão-Côrtes, V. R., Paré, P., Tovo-Rodrigues, L., Vieira, C. M. D. A. G., Xavier, A., Comas, D., Pissinatti, A., Sinigaglia, M., Rigo, M. M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419399112 · Cited by 59
“Although 3D crystal structures of GPCRs are known, they present less than 29% similarity with OXTR.”
BackgroundInfluentialModulation of cellular signaling by herpesvirus-encoded G protein-coupled receptors
de Munnik, S. M., Smit, M. J., Leurs, R., & Vischer, H. F. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00040 · Cited by 63
“Factors that contribute to the stability of the GPCR/β-arrestin interaction include the presence of phosphorylated S/T clusters in the C-terminus of GPCRs (Oakley et al., 2001; Luttrell and Lefkowitz, 2002) and ubiquitination of β-arrestin (Shenoy and Lefkowitz, 2003).”
BackgroundSnyder, J. C., Rochelle, L. K., Lyerly, H. K., Caron, M. G., & Barak, L. S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.447540 · Cited by 62
“TSSS is similar to those observed in other GPCRs, and these motifs are primarily associatedwith stable receptor/ -arrestin2 complexes that internalize through clathrin-coated pits (18, 19).”
BackgroundUncoupling and Endocytosis of 5-Hydroxytryptamine 4 Receptors
Barthet, G., Gaven, F., Framery, B., Shinjo, K., Nakamura, T., Claeysen, S., Bockaert, J., & Dumuis, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502272200 · Cited by 59
Olivares-Reyes, J. A., Smith, R. D., Hunyady, L., Shah, B. H., & Catt, K. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106368200 · Cited by 57
Simaan, M., Bédard-Goulet, S., Fessart, D., Gratton, J., & Laporte, S. A. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2004.12.001 · Cited by 55
Tracking the opioid receptors on the way of desensitization
Marie, N., Aguila, B., & Allouche, S. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.03.015 · Cited by 54
Callander, G. E., Thomas, W. G., & Bathgate, R. A. D. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00581.2008 · Cited by 53
Transmembrane Signaling by G Protein–Coupled Receptors
Jacob, C., & Bunnett, N. W. (2006) · Elsevier eBooks · doi:10.1016/b978-012088394-3/50006-4 · Cited by 53
Novel roles for arrestins in the post-endocytic trafficking of G protein-coupled receptors
Prossnitz, E. R. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.04.003 · Cited by 52
Tóth, A. D., Prokop, S., Gyombolai, P., Várnai, P., Balla, A., Gurevich, V. V., Hunyady, L., & Turu, G. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.813139 · Cited by 50
“It is known that phosphorylated serine–threonine clusters in the receptor C terminus participate in the stabilization of the arrestin–receptor complex (14), however, the structural basis of stable -arrestin–receptor coupling is still poorly understood.”
BackgroundResultLowe, J., Celver, J. P., Gurevich, V. V., & Chavkin, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200612200 · Cited by 52
Regulation of Epidermal Growth Factor Receptor Internalization by G Protein-Coupled Receptors
Kim, J., Ahn, S., Guo, R., & Daaka, Y. (2003) · Biochemistry · doi:10.1021/bi026942t · Cited by 52
How Carvedilol activates β2-adrenoceptors
Benkel, T., Zimmermann, M., Zeiner, J., Bravo, S., Merten, N., Lim, V., Matthees, E. S. F., Drube, J., Miess, E., Malan, D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34765-w · Cited by 52
“This modi fi cation converts β 2 AR from a transient (class A) to a stable (class B) arrestin-binder 91 to produce long-lived receptor arrestin complexes 92,93 .”
BackgroundPharmacological characterization of a small‐molecule agonist for the chemokine receptor CXCR3
Scholten, D. J., Canals, M., Wijtmans, M., de Munnik, S., Nguyen, P., Verzijl, D., de Esch, I. J. P., Vischer, H. F., Smit, M. J., & Leurs, R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01648.x · Cited by 49
“VUF10661 induces internalization of CXCR3 Upon sustained agonist stimulation, GPCRs are generally removed from the cell surface, a process called endocytosis or internalization (Ferguson et al., 1996).”
BackgroundInfluentialIdentification and Profiling of Novel α1A-Adrenoceptor-CXC Chemokine Receptor 2 Heteromer
Mustafa, S., See, H. B., Seeber, R. M., Armstrong, S. P., White, C. W., Ventura, S., Ayoub, M. A., & Pfleger, K. D. G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.322834 · Cited by 51
“(59, 60), it is phosphorylated much more weakly than 1BAR, which contains none of FIGURE 5.”
BackgroundEmerging Role of Compartmentalized G Protein-Coupled Receptor Signaling in the Cardiovascular Field
Plouffe, B., Thomsen, A. R. B., & Irannejad, R. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00006 · Cited by 47
A ghrelin receptor and oxytocin receptor heterocomplex impairs oxytocin mediated signalling
Wallace Fitzsimons, S. E., Chruścicka, B., Druelle, C., Stamou, P., Nally, K., Dinan, T. G., Cryan, J. F., & Schellekens, H. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.12.022 · Cited by 49
Rose, R. H., Briddon, S. J., & Holliday, N. D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00480.x · Cited by 49
“Irreversibility can also become an important consideration because some ligands and 7TM receptors (such as the b2-adrenoceptor) recruit b-arrestin transiently, while others form stable receptor-b-arrestin complexes which persist in endosomes (Oakley et al., 2001).”
BackgroundRole of beta-arrestin 2 downstream of dopamine receptors in the basal ganglia
Del’Guidice, T. (2011) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2011.00058 · Cited by 53
Inagaki, S., Ghirlando, R., Vishnivetskiy, S. A., Homan, K. T., White, J. F., Tesmer, J. J. G., Gurevich, V. V., & Grisshammer, R. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00285 · Cited by 47
Qiu, Y. L., Loh, H. H., & Law, P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611258200 · Cited by 49
Parathyroid Hormone Receptor Recycling: Role of Receptor Dephosphorylation and β-Arrestin
Chauvin, S., Bencsik, M., Bambino, T., & Nissenson, R. A. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0049 · Cited by 49
Bhattacharyya, S., Hope, T. J., & Young, J. A. T. (2011) · Virology · doi:10.1016/j.virol.2011.07.018 · Cited by 50
“By contrast, ARRB1, which is selectively important for MARVGP-mediated infection, recognizes phosphorylated serine and threonine residues onGPCRs (Oakley et al., 2001) andbinds both to the beta-adaptin subunit of AP-2 as well as directly to clathrin through its C-terminus (Traub, 2003;Traub, 2009).”
BackgroundOligny-Longpré, G., Corbani, M., Zhou, J., Hogue, M., Guillon, G., & Bouvier, M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112422109 · Cited by 47
“To confirm that the recruitment of β-arrestins to IGFR and not V2R is responsible for the V2R-mediated ERK1/2 activation, we took advantage of a mutant form of V2R [V2R (Ala6)] in which phosphate acceptor residues that stabilize the receptor’s interaction with β-arrestins were replaced by alanines (37), thus decreasin…”
BackgroundRichardson, M. D., Balius, A. M., Yamaguchi, K., Freilich, E. R., Barak, L. S., & Kwatra, M. M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01577.x · Cited by 47
Schmidlin, F., Roosterman, D., & Bunnett, N. W. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00541.2002 · Cited by 47
Key, T. A., Foutz, T. D., Gurevich, V. V., Sklar, L. A., & Prossnitz, E. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m204687200 · Cited by 47
Biased Signaling and Allosteric Modulation at the FSHR
Landomiel, F., Pascali, F. D., Raynaud, P., Jean‐Alphonse, F., Yvinec, R., Pellissier, L. P., Bozon, V., Bruneau, G., Crépieux, P., Anne Poupon, B., et al. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00148 · Cited by 46
Ligand-specific receptor states: Implications for opiate receptor signalling and regulation
Piñeyro, G., & Archer-Lahlou, É. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.05.026 · Cited by 45
Dalrymple, M. B., Jaeger, W. C., Eidne, K. A., & Pfleger, K. D. G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.223537 · Cited by 45
ML314: A Biased Neurotensin Receptor Ligand for Methamphetamine Abuse
Barak, L. S., Bai, Y., Peterson, S. M., Evron, T., Urs, N. M., Peddibhotla, S., Hedrick, M. P., Hershberger, P., Maloney, P., Chung, T. D. Y., et al. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00291 · Cited by 44
β-arrestin signalling and bias in hormone-responsive GPCRs
Reiter, É., Ayoub, M. A., Pellissier, L. P., Landomiel, F., Musnier, A., Trefier, A., Gandía, J., Pascali, F. D., Tahir, S., Yvinec, R., et al. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.01.052 · Cited by 45
“…S/T in C-term Gi1/Gi3 bias; β-arr bias; Gq bias (Azzi et al., 2003,Busnelli et al., 2012,Busnelli et al., 2013,Di Benedetto et al., 2014,Hasbi et al., 2004,Oakley et al., 2001,Passoni et al., 2016,Terrillon and Bar-Sagi, 2008) Adrenaline, epinephrine α1AR, α2AR, β1AR, β2AR, β3AR Microscopy,…”
Signaling at the endosome: cryo‐EM structure of a GPCR–G protein–beta‐arrestin megacomplex
Nguyen, A. H., & Lefkowitz, R. J. (2021) · FEBS Journal · doi:10.1111/febs.15773 · Cited by 44
Estall, J. L., Koehler, J. A., Yusta, B., & Drucker, D. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500078200 · Cited by 45
Walther, C., & Ferguson, S. S. G. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394440-5.00004-8 · Cited by 44
Gyombolai, P., Boros, E., Hunyady, L., & Turu, G. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.03.013 · Cited by 43
“Our findings demonstrating a class A pattern for CB1R are in good agreement with this theory, as the C-terminus of CB1R contains only one such cluster (463-SVSTDTS-469) (Oakley et al., 2001).”
BackgroundResultInfluentialGimenez, L. E., Ghildyal, P., Fischer, K. E., Hu, H., Ja, W. W., Eaton, B. A., Wu, Y., Austad, S. N., & Ranjan, R. (2012) · Aging Cell · doi:10.1111/acel.12027 · Cited by 42
“Furthermore, b-arrestin is known to have a high affinity for secretin family GPCRs like MTH (Oakley et al., 2001).”
BackgroundGrotegut, C. A., Feng, L., Mao, L., Heine, R. P., Murtha, A. P., & Rockman, H. A. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00390.2010 · Cited by 43
“Mutations of the OXTR in this highly conserved region of serine clusters within the carboxyl-terminal domain lead to unstable OXTR-arrestin interactions and failure of receptor internalization following agonist stimulation (33).”
BackgroundResultInfluentialZhang, X., Wang, F., Chen, X., Chen, Y., & Ma, L. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05431.x · Cited by 43
Biased Signaling of the Angiotensin II Type 1 Receptor Can Be Mediated through Distinct Mechanisms
Bonde, M. M., Hansen, J. T., Sanni, S. J., Haunsø, S., Gammeltoft, S., Lyngsø, C., & Hansen, J. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014135 · Cited by 41
“Truncation or mutation of serine or threonine residues in the C-terminal tail has been shown to disrupt this stable interaction with b-arrestin leading to increased signaling through G protein-dependent pathways [24,25,26,27,28,29].”
BackgroundArresting angiotensin type 1 receptors
Thomas, W. G., & QIAN, H. (2003) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(03)00023-7 · Cited by 43
β-Arrestin-2 BRET Biosensors Detect Different β-Arrestin-2 Conformations in Interaction with GPCRs
Oishi, A., Dam, J., & Jockers, R. (2019) · ACS Sensors · doi:10.1021/acssensors.9b01414 · Cited by 43
Exploring GPCR‐arrestin interfaces with genetically encoded crosslinkers
Böttke, T., Ernicke, S., Serfling, R., Ihling, C. H., Burda, E., Gurevich, V. V., Sinz, A., & Coin, I. (2020) · EMBO Reports · doi:10.15252/embr.202050437 · Cited by 45
“Other receptors forming stable complexes with arrestin include the angiotensin II type 1 receptor (AT 1 R), the oxytocin receptor, the neuro-tensin 1 receptor (NTS 1 R), and the secretin-like parathyroid hormone receptor (PTH1R) (Oakley et al , 2001; Vilardaga et al , 2002).”
Krishnamurthy, H., Galet, C., & Ascoli, M. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(03)00088-1 · Cited by 42
Stadler, B., Whittaker, M. R., Exintaris, B., & Middendorff, R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.565731 · Cited by 43
Willets, J. M., Brighton, P. J., Mistry, R., Morris, G. E., Konje, J. C., & Challiss, R. A. J. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0047 · Cited by 41
Amphioxus (Branchiostoma floridae) has orthologs of vertebrate odorant receptors
Churcher, A. M., & Taylor, J. S. (2009) · BMC Evolutionary Biology · doi:10.1186/1471-2148-9-242 · Cited by 42
“floridae ORs should be confirmed experimentally, however, the presence of several clusters of serine and threonine residues in the C termini suggests they may be sites for receptor phosphorylation as seen in other GPCRs [34,35].”
BackgroundKilpatrick, L. E., Briddon, S. J., & Holliday, N. D. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.03.002 · Cited by 40
β-Arrestins: Multitask Scaffolds Orchestrating the Where and When in Cell Signalling
Laporte, S. A., & Scott, M. G. H. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9158-7_2 · Cited by 41
Oh, D. Y., Song, J. A., Moon, J. S., Moon, M. J., Kim, J. I., Kim, K., Kwon, H. B., & Seong, J. Y. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0220 · Cited by 40
“The SFR motif and SMSS in the 2/3 fragment might serve as binding sites for PKC and -arrestin, respectively (37, 49).”
Backgroundβ-Arrestins bind and decrease cell-surface abundance of the Na + /H + exchanger NHE5 isoform
Szabó, E. Z., Numata, M., Lukashova, V., Iannuzzi, P., & Orlowski, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407444102 · Cited by 40
Ma, W.-J., Hashii, M., Munesue, T., Hayashi, K., Yagi, K., Yamagishi, M., Higashida, H., & Yokoyama, S. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-22 · Cited by 46
“The amino acid variation R376G/C is located in the intracellular carboxy (C)-terminal tail of the receptor protein, which is critical for desensitization, internalization, and recycling of the OXTR, as in many other GPCRs [9-13].”
BackgroundInfluentialRasmussen, T. N., Novak, I., & Nielsen, S. M. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04371.x · Cited by 40
Beneath the surface: endosomal GPCR signaling
Flores-Espinoza, E., & Thomsen, A. R. B. (2024) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2024.03.006 · Cited by 46
Biological properties and functional determinants of the urotensin II receptor
Proulx, C. D., Holleran, B. J., Lavigne, P., Escher, E., Guillemette, G., & Leduc, R. (2007) · Peptides · doi:10.1016/j.peptides.2007.10.027 · Cited by 39
Agonist-biased Trafficking of Somatostatin Receptor 2A in Enteric Neurons
Zhao, P., Canals, M., Murphy, J. E., Klingler, D., Eriksson, E. M., Pelayo, J., Hardt, M., Bunnett, N. W., & Poole, D. P. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.496414 · Cited by 39
Differential Regulation of Endosomal GPCR/β-Arrestin Complexes and Trafficking by MAPK
Khoury, E., Nikolajev, L., Simaan, M., Namkung, Y., & Laporte, S. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.568147 · Cited by 39
“This contrasted with wild type -arrestin, which, as we showed previously, can be recruited at the plasma membrane upon agonist activation of 2AR, but does not internalize into endosomes with the receptor (29, 30).”
BackgroundEndothelin-Converting Enzyme-1 Degrades Internalized Somatostatin-14
Roosterman, D., Kempkes, C., Cottrell, G. S., Padilla, B. E., Bunnett, N. W., Turck, C. W., & Steinhoff, M. S. (2008) · Endocrinology · doi:10.1210/en.2007-1628 · Cited by 39
“They are functionally characterized by a long-lasting sequestration after stimulation with high concentrations of the agonist (8, 9).”
Chen, J., Chen, X., Li, S., Jiang, Y., Mao, H., Zhang, R., Ji, B., Yan, M., Cai, X., & Wang, C. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101629 · Cited by 39
Laferrière, A., Liu, J., & Moss, I. R. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(02)00915-2 · Cited by 39
Metadata
- Authors
- Oakley, R. H., Laporte, S. A., Holt, J. A., Barak, L. S., & Caron, M. G.
- Affiliations
- Howard Hughes Medical Institute (US)
- Corresponding author
- Caron, Marc G.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-06
- Volume
- 276
- Issue
- 22
- Pages
- 19452-19460
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2083334427
- Cited by
- 455
- References
- 45
- Citations by year
- 2026: 7 · 2025: 19 · 2024: 8 · 2023: 15 · 2022: 14 · 2021: 13 · 2020: 16 · 2019: 10 · 2018: 11 · 2017: 23 · 2016: 9 · 2015: 9 · 2014: 18 · 2013: 17 · 2012: 19
- FWCI
- 10.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl061365-04)
- National Heart, Lung, and Blood Institute (HL61365)
- National Institute of Neurological Disorders and Stroke (NS-19576, R01NS019576)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- beta-arrestin, G protein-coupled receptors, receptor internalization, receptor desensitization, receptor resensitization, serine/threonine phosphorylation, carboxyl-terminal tail, beta2-adrenergic receptor, oxytocin receptor, angiotensin II type 1a receptor, neurokinin-1 receptor, endocytic vesicles
- MeSH terms
- beta-Arrestins, beta-Arrestin 2, Amino Acid Sequence, Cell Line, Cell Membrane, Endocytosis, Humans, Luminescent Proteins, Microscopy, Fluorescence, Molecular Sequence Data, Mutation, Phosphorylation, Plasmids, Protein Binding, Receptors, Angiotensin, Receptors, Cell Surface, Recombinant Fusion Proteins, Time Factors, Transfection, Mutagenesis, Site-Directed, Sequence Homology, Amino Acid, Protein Structure, Tertiary, Receptors, Neurotensin, Receptors, Neurokinin-1, Receptors, Oxytocin, Microscopy, Confocal, Arrestins, Receptor, Angiotensin, Type 1, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review